MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 253 filers reported holding MYRIAD GENETICS INC in Q4 2017. The put-call ratio across all filers is 0.68 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $6,636,000 | -36.8% | 228,220 | 0.0% | 0.03% | -28.6% |
| Q3 2018 | $10,499,000 | +23.1% | 228,220 | 0.0% | 0.04% | +7.7% |
| Q2 2018 | $8,530,000 | +26.5% | 228,220 | 0.0% | 0.04% | +21.9% |
| Q1 2018 | $6,744,000 | +12.8% | 228,220 | +31.1% | 0.03% | +3.2% |
| Q4 2017 | $5,979,000 | +96.5% | 174,098 | +122.7% | 0.03% | +40.9% |
| Q2 2014 | $3,043,000 | +13.8% | 78,188 | 0.0% | 0.02% | +4.8% |
| Q1 2014 | $2,673,000 | +63.0% | 78,188 | 0.0% | 0.02% | +50.0% |
| Q4 2013 | $1,640,000 | -10.7% | 78,188 | 0.0% | 0.01% | -22.2% |
| Q3 2013 | $1,837,000 | -12.6% | 78,188 | 0.0% | 0.02% | -14.3% |
| Q2 2013 | $2,101,000 | – | 78,188 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 2,750,000 | $75,900,000 | 2.61% |
| PFM Health Sciences, LP | 2,025,681 | $55,909,000 | 1.90% |
| Tieton Capital Management, LLC | 118,456 | $3,269,000 | 1.83% |
| Altium Capital Management LP | 190,000 | $5,244,000 | 1.45% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,846,490 | $50,963,000 | 1.03% |
| EARNEST PARTNERS LLC | 6,316,365 | $174,332,000 | 1.01% |
| Glenview Capital Management | 1,679,747 | $46,361,000 | 0.99% |
| Zebra Capital Management LLC | 14,209 | $392,000 | 0.63% |
| AIMZ Investment Advisors, LLC | 44,185 | $1,220,000 | 0.48% |
| Phocas Financial Corp. | 132,101 | $3,646,000 | 0.46% |